Amubarvimab (BRII-196) is a humanized recombinant antibody targeting the spike protein of SARS-CoV-2, with antiviral activity, used in studies of COVID-19 infection.
Purity:
95.00%
CAS Number:
[2509447-07-6]
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted